KIRKMAN ROBERT L 4/A
4/A · Oncothyreon Inc. · Filed Mar 18, 2009
Insider Transaction Report
Form 4/AAmended
Oncothyreon Inc.ONTY
KIRKMAN ROBERT L
DirectorPresident/CEO
Transactions
- Award
Stock Option (right to buy)
2009-03-11+100,000→ 100,000 totalExercise: $1.10Exp: 2017-03-11→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The option vests in four equal annual installments beginning on March 11, 2010.
- [F2]The exercise price of this stock option was incorrectly stated on the original filing.